Charles River Labs (CRL) stock and LabCorp (LH) stock were upgraded and Quest Diagnostics (DGX) stock was downgraded at Citi.

Since a new CEO moved Surgical Solutions to Kansas City 17 months ago, the company has been making significant strides, ...

Shares of Labcorp Holdings Inc. LH rose 1.31% to $251.04 Friday, on what proved to be an all-around positive trading session ...

LH stays on investors' radar owing to its strong focus on high-growth areas and pursuing strategic acquisitions.

Labcorp has been a great trade, beating the S&P 500 by 6.9%. Its stock price has climbed to $255.01, representing a healthy ...

Texas doctors said there's no harm in getting another measles vaccine if you don't know whether you were vaccinated as a ...

Fintel reports that on March 4, 2025, Citigroup upgraded their outlook for Labcorp Holdings (NYSE:LH) from Neutral to Buy.

Citi upgraded Labcorp (LH) to Buy from Neutral with a price target of $300, up from $250. Utilization rates have been running high ...

A vehicle crashed into the LabCorp business at 595 Loudon Rd in Newton Plaza II on March 4, causing significant damage to the ...

A Wall Street analyst issued contrasting ratings on Tuesday for two major diagnostic testing companies, upgrading shares of ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the clinical availability of Labcorp® Plasma CompleteTM, a circulating tumor DNA (ctDNA)-based ...

According to Benzinga Pro, Labcorp Hldgs's peer group average for short interest as a percentage of float is 9.75%, which ...